Although we still lack an exclusive tumor-cell-derived BC marker for EVs, some tumor markers, such as CD49f or the epithelial cell-specific marker (EpCAM), have shown promising results in this regard [106]. This evidence concerns the gene ITGA6 and neoplasm.